MODIFICATION OF IN-SITU GELLING BEHAVIOR OF CARBOPOL SOLUTIONS BY HYDROXYPROPYL METHYLCELLULOSE

被引:93
作者
KUMAR, S [1 ]
HIMMELSTEIN, KJ [1 ]
机构
[1] UNIV NEBRASKA,MED CTR,DEPT PHARMACEUT SCI,OMAHA,NE 68198
关键词
D O I
10.1002/jps.2600840315
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Aqueous solutions of Carbopol [polyacrylic acid (PAA)] are low viscosity acidic solutions that transform into gels upon an increase in the pH and, therefore, may be used as in situ gelling ophthalmic drug delivery systems. However, the amount of PAA required in the solution to form stiff gels upon instillation in the eye is not easily neutralized by the buffering action of tear fluid. A reduction in the PAA concentration without compromising the in situ gelling properties as well as the overall theological behavior of the system can be achieved by adding a suitable viscosity-enhancing polymer. The rheological properties of aqueous solutions containing PAA and hydroxypropyl methylcellulose (HPMC), a viscosity-enhancing polymer, evaluated as a function of temperature and pH, were similar to those of pure PAA solutions; that is, both form low viscosity liquids at pH 4.0 and transform into stiff gels with plastic theological behavior and comparable viscosities upon increasing the pH to 7.4. In addition, HPMC-PAA gels show slow in vitro release of incorporated timolol maleate. Thus, the HPMC-PAA combination demonstrates properties suitable for formulation as a liquid ophthalmic delivery systems, which upon instillation into the cul-de-sac of the eye can undergo in situ phase transition to form gels capable of sustained drug release.
引用
收藏
页码:344 / 348
页数:5
相关论文
共 14 条
[1]  
CHANDRASEKRAN SK, 1989, Patent No. 6964
[2]  
CHEIN YW, DRUGS PHARM SCI, V14, P13
[3]  
GURNY R, 1985, Journal of Controlled Release, V2, P353, DOI 10.1016/0168-3659(85)90057-4
[4]  
Haslam JL, 1984, US Patent, Patent No. [4:474-752, 4474752]
[5]  
Joshi A., 1993, US Patent, Patent No. [5, 252-318, 5252318]
[6]   IN SITU-FORMING GELS FOR OPHTHALMIC DRUG-DELIVERY [J].
KUMAR, S ;
HAGLUND, BO ;
HIMMELSTEIN, KJ .
JOURNAL OF OCULAR PHARMACOLOGY, 1994, 10 (01) :47-56
[7]  
LEE VHL, 1993, DRUG PHARM SCI, V58, P59
[8]   IN-VITRO RELEASE OF TIMOLOL MALEATE FROM AN IN-SITU GELLING POLYMER SYSTEM [J].
LINDELL, K ;
ENGSTROM, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 95 (1-3) :219-228
[9]   EFFECT OF POLOXAMER 407 GEL ON THE MIOTIC ACTIVITY OF PILOCARPINE NITRATE IN RABBITS [J].
MILLER, SC ;
DONOVAN, MD .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1982, 12 (2-3) :147-152
[10]   IMPROVING THE SAFETY OF TOPICALLY APPLIED TIMOLOL IN THE PIGMENTED RABBIT THROUGH MANIPULATION OF FORMULATION COMPOSITION [J].
PODDER, SK ;
MOY, KC ;
LEE, VHL .
EXPERIMENTAL EYE RESEARCH, 1992, 54 (05) :747-757